Biodesix, Inc. (NASDAQ:BDSX) Q4 2022 Earnings Call Transcript

Page 5 of 5

So, I would expect it continues to see coverage policies roll in for Nodify XL2 validating that utility statement. And then now that we have Nodify CDT coverage from Medicare starting to see some private payer coverage for Nodify CDT this year.

Scott Hutton: Andrew, did you get that? Are you still with us?

Robin Harper Cowie: Looks like we might have lost Andrew.

Scott Hutton: Operator, I think we dropped Andrew with William Blair. I don’t know if there are any other additional questions?

Operator: There are no other questions in the queue. This concludes today’s conference call. Thank you for participating. You may now disconnect.

Follow Biodesix Inc

Page 5 of 5